One of the first Hawaiian volcanic water brands, Waiakea Hawaiian Bottled Water, is now one of the fastest growing companies in America. Growing fast enough to be ranked 414 on the Inc. 5000 list. Its impressive growth of 1,059.3% has been at such a staggering rate that it now ranks up there with companies such as Microsoft and GoPro. Founder Ryan Emmons is thrilled to be on the list. With his unique vision of moral and social responsibilities to its clients and planet at large he has establish a new way to run a business successfully. It truly cares about society at large.
Its unique platform of health, charity, and sustainability was what the founder intended during its creation in 2012. Waiakea Hawaiian Bottled Water has a focus on clean water
access and environmental conservation shows it truly cares about people and the entire planet and wishes to inspire positive change. Rain and snow are filtered through porous lava
of Mauna Loa volcano
which gives it a great and distinctive taste. As part of its sustainability objective it has been awarded a carbon neutral certification. One of the few companies out there to receive this award, it prides itself of being the World’s Greenest water brand
Waiakea Hawaiian Bottled Water has established reforestation projects to conserve the environment as well as developed sustainable sourcing and packaging showing its respect for the land. Providing access to clean water to those less fortunate show its commitment to society. There commitment to a zero carbon environment is also admirable. Waiakea Hawaiian Bottled Water has out shined other brands to receive plenty of awards including The 2015 Food and Beverage Innovation Award 2015, The Finalist, Packaging Design and Taste Awards, and #2 Leading Bottled Water Brands 2016 globally. Its really been racking up those awards.
Waiakea donates 650 liters of clean water for every liter of water they sell for its helping to end thirst in Africa. It has partnered with Pump Aid to help disadvantaged communities. Because of this partnership over one million people has access to clean drinking water and sanitation.
Eric Lefkofsky is known in the tech world as the co-founder and developer of giants like Groupon, Mediaocean, and InnerWorkings. Curating and cultivating companies of that caliber grew Lefkofsky’s wealth to a staggering $1.7 billion according to Forbes. Having laid the foundation for his life, he exited the world of startup companies and set out to never have to be involved in that labor intensive process again.
That fact would have remained true, but then Lefkofsky’s wife Liz was diagnosed breast cancer. When they were thrown into the world of a cancer patient and the loved one of a cancer patient, they quickly realized all the many gaps in the ability of oncologists to provide a comprehensive list options for treatment. Not one to be a passive participant in an important process like this, Lefkofsky developed Tempus.
Tempus’ overall goal is to provide usable data to health care providers. In order to achieve this, the company had to establish connections with some of the nations leading medical facilities. Physicians at the Mayo Clinic, Northwestern University, the University of Chicago, and the University of Michigan send their patients that are diagnosed with cancer to Tempus. From there, each person is sequenced in Tempus’ labs. At this point the patient’s individual molecular and clinical information are input into the database. The physician that originally sent the patient to Tempus is then given access to the system and is able to see what mutations the patient may have. It also allows them to see treatment histories for the patient’s mutation type and what approaches worked best on a retroactive basis. At its core, Tempus is still a data company, but the data is then translated to be a productive tool for the health care medical community.
The model of Tempus is the first of its kind and has the potential to create life altering results. The impact of Tempus has yet to be fully realized as it is still in its infancy, but when those results make themselves known, they will be astounding for the medical community.